Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B

Clinical utility of hepatitis B surface

Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

✍ Yun-Fan Liaw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin

Clinical utility of hepatitis B surface

Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

✍ Yun-Fan Liaw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin

Correction: “Clinical utility of hepatit

Correction: “Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review”

📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

In the June 2011 issue of HEPATOLOGY, in the article entitled ''Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review'' (volume 53, pages 2121-2129) the data in Tables 2 and3 are to be corrected as listed below: On page 2124, under the heading '

Predicting fat in diets of marital partn

Predicting fat in diets of marital partners using the health belief model

✍ Robert B. Schafer; Pat M. Keith; Elisabeth Schafer 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 693 KB

Symptomatology and health attitudes of c

Symptomatology and health attitudes of chronic hepatitis B patients in the USA

✍ H.-W. Hann; S.-H. Han; T. M. Block; M. Harris; J.-F. Maa; R. T. Fisher; E. Atill 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Prediction of significant fibrosis in HB

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

✍ Min-De Zeng; Lun-Gen Lu; Yi-Min Mao; De-Kai Qiu; Ji-Qiang Li; Mo-Bin Wan; Cheng- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

A model was constructed consisting of clinical and serum variables to discriminate between hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients with and without significant fibrosis (stages 2-4 vs. stages 0-1). Consecutive treatment-naive CHB patients who underwent liver biopsy